Cognito's light-and-sound Alzheimer's headset fails pivotal trial
Cognito Therapeutics' Spectris AD device, which uses flickering light and rhythmic sound to induce gamma waves, failed to meaningfully slow Alzheimer's disease progression in its long-anticipated Phase 3 trial.
·2 sources